Natera Shares Approach Critical Earnings Test

Natera Inc. finds itself at a pivotal moment as it prepares to release third-quarter 2025 financial results after market close on Thursday. The diagnostics company’s shares, which recently reached an unprecedented peak of $199.04, face intense scrutiny from investors awaiting what could be the year’s most significant trading session. While the stock last settled at $198.93, early indications suggest a modest retreat to around $196.81 at the opening bell.

Analysts project quarterly revenue of $514.77 million for Natera, representing a 17.06% year-over-year increase. This optimism persists despite the company’s previous quarterly performance, where it reported a loss of $0.74 per share while simultaneously delivering impressive revenue growth of 32.2% to $546.6 million.

The company’s Read more...